MLAB
Mesa Laboratories, Inc.
104.39
2 x 75.03
2 x 127.39
bid
ask
+
4.84
4.86%
2 @ 04:00 PM
108.47 +4.08 (3.91%)
| Ytd | 32.98% | |
| 1y | 6.84% |
99.53
day range
106.12
55.45
52 week range
113.99
| Open | 99.53 | Prev Close | 99.55 | Low | 99.53 | High | 106.12 | Mkt Cap | 576.75M |
| Vol | 142.21K | Avg Vol | 174.90K | EPS | 1.21 | P/E | 86.27 | Forward P/E | 18.42 |
| Beta | 0.86 | Short Ratio | 3.64 | Inst. Own | 91.88% | Dividend | 0.64 | Div Yield | 0.48 |
| Ex Div Date | 11-29 | Earning | 08-05 | 50-d Avg | 101.83 | 200-d Avg | 86.39 | 1yr Est | 133.33 |
| Income Statement | |||
| Total Revenue | 63.72M | ||
| Revenues (USD) | 63.72M | ||
| Cost of Revenue | 21.52M | ||
| Gross Profit | 42.21M | ||
| Operating Expenses | 39.46M | ||
| Research and Development Expense | 5.25M | ||
| Selling, General and Administrative Expense | 34.21M | ||
| Operating Income | 2.75M | ||
| Interest Expense | 2.60M | ||
| Income Tax Expense | 2.54M | ||
| Net Income | -4.14M | ||
| Net Income Common Stock | -4.14M | ||
| Net Income Common Stock (USD) | -4.14M | ||
| Consolidated Income | -4.14M | ||
| Earnings per Basic Share | -0.75 | ||
| Earnings per Basic Share (USD) | -0.75 | ||
| Earnings per Diluted Share | -0.74 | ||
| Dividends per Basic Common Share | 0.16 | ||
| Earning Before Interest & Taxes (EBIT) | 1.00M | ||
| Earning Before Interest & Taxes (USD) | 1.00M | ||
| Weighted Average Shares | 5.54M | ||
| Weighted Average Shares Diluted | 5.60M | ||
| Balance Sheet | |||
| Cash and Equivalents | 26.93M | ||
| Cash and Equivalents (USD) | 26.93M | ||
| Trade and Non-Trade Receivables | 44.10M | ||
| Current Assets | 106.27M | ||
| Property, Plant & Equipment Net | 30.61M | ||
| Total Assets | 427.75M | ||
| Debt Current | 5.63M | ||
| Total Debt | 151.48M | ||
| Current Liabilities | 61.90M | ||
| Debt Non-Current | 145.86M | ||
| Total Liabilities | 241.50M | ||
| Accumulated Retained Earnings (Deficit) | -185.75M | ||
| Accumulated Other Comprehensive Income | -3.36M | ||
| Shareholders Equity | 186.25M | ||
| Shareholders Equity (USD) | 186.25M | ||
| Assets Non-Current | 321.48M | ||
| Total Debt (USD) | 151.48M | ||
| Deferred Revenue | 14.72M | ||
| Goodwill and Intangible Assets | 270.21M | ||
| Inventory | 26.37M | ||
| Liabilities Non-Current | 179.60M | ||
| Trade and Non-Trade Payables | 4.93M | ||
| Tax Assets | 1.50M | ||
| Tax Liabilities | 20.09M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 5.75M | ||
| Net Cash Flow from Financing | -15.76M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -2.05M | ||
| Capital Expenditure | -417.00K | ||
| Issuance (Repayment) of Debt Securities | -14.69M | ||
| Payment of Dividends & Other Cash Distributions | -884.00K | ||
| Net Cash Flow from Investing | -417.00K | ||
| Net Cash Flow from Operations | 13.96M | ||
| Effect of Exchange Rate Changes on Cash | 167.00K | ||
| Share Based Compensation | 6.79M | ||